Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
暂无分享，去创建一个
J. Bartek | G. Velimezi | T. Halazonetis | V. Gorgoulis | A. Kotsinas | C. Kittas | D. Ginsberg | G. Tsangaris | K. Evangelou | M. Liontos | K. Niforou | V. Zoumpourlis | K. Vougas | R. Vrtel | K. Apostolopoulou | A. Damalas | P. Kontovazenitis | Georgia Velimezi